Wagg, A., Franks, B., Ramos, B., & Berner, T. (2015). Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Can Urol Assoc J.
Chicago-tyylinen lähdeviittausWagg, Adrian, Billy Franks, Barbara Ramos, ja Todd Berner. "Persistence and Adherence With the New Beta-3 Receptor Agonist, Mirabegron, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada." Can Urol Assoc J 2015.
MLA-viiteWagg, Adrian, Billy Franks, Barbara Ramos, ja Todd Berner. "Persistence and Adherence With the New Beta-3 Receptor Agonist, Mirabegron, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada." Can Urol Assoc J 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.